2021
Species distribution and antifungal susceptibility of Aspergillus clinical isolates in Lebanon
Osman M, Bidon B, Abboud C, Zakaria A, Hamze B, Achcar M, Mallat H, Dannaoui E, Dabboussi F, Papon N, Bouchara J, Hamze M. Species distribution and antifungal susceptibility of Aspergillus clinical isolates in Lebanon. Future Microbiology 2021, 16: 13-26. PMID: 33438473, DOI: 10.2217/fmb-2020-0141.Peer-Reviewed Original ResearchConceptsAntifungal susceptibilityAspergillus clinical isolatesAntifungal susceptibility patternsReverse transcription-quantitative PCRNational Reference CenterOverall drug resistanceTranscription-quantitative PCRInvasive mycosesSusceptibility patternsHealth strategiesEUCAST recommendationsReference centerClinical isolatesAmphotericin BDrug resistanceResistant isolatesMajor causeGene mutationsExpression levelsIsolatesEpidemiologySusceptibilityMycoses
2019
Fungal Immunoepidemiology
Azar M. Fungal Immunoepidemiology. 2019, 179-191. DOI: 10.1007/978-3-030-25553-4_11.Peer-Reviewed Original ResearchFungal infectionsImmune responseImmune defenseHost immune responsePublic health impactImportant fungal infectionsSpecific innateImmunocompetent populationAntifungal vaccinesInvasive mycosesInfectionImmunoepidemiologyFungal recognitionCritical pathwaysHealth impactsDisease susceptibilityAdaptive responseResponseCoccidiomycosisMorbidityPredisposesImmunodeficiencyVaccinePopulationInnate
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply